Red Clover Isoflavones Cardiovascular Health

Heart risk markers begin shifting in perimenopause, before menopause itself. What red clover isoflavone evidence supports here, and what it does not.

Endothelial cells regulate vessel tone through nitric oxide. What red clover isoflavone trials in postmenopausal women measured on that function.

LDL, total cholesterol, triglycerides and HDL respond differently in red clover trials. A marker-by-marker look at what the lipid evidence supports.

Lipids, blood pressure and vascular function shift together through menopause. How red clover research addresses each risk factor, and where its limits are.

Blood pressure often shifts through menopause. What the research on red clover isoflavones and blood pressure actually reports, and the mechanisms suggested.

Arterial stiffness rises through the menopausal transition. What red clover research has measured on vascular elasticity, and the mechanisms proposed.

Metabolic syndrome research on red clover is early and largely preclinical. What sprout and formononetin studies suggest, and why that is not yet advice.

Cholesterol often rises through the menopausal transition. What red clover research has found on lipid markers, and the mechanisms proposed to explain it.

Blood pressure evidence for red clover leans heavily on preclinical work. What animal and vascular studies suggest, and how thin the human data really is.

Endothelial function, lipid profiles and antioxidant activity are the three routes proposed for red clover and midlife heart health. What each rests on.